FRIEDMAN CATHY

Insider profile

Performance

Overall performance
0.6

Performance over holding periods
0.6
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
FRIEDMAN CATHY's trades of Lyell Immunopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-06-23 2021-06-21 B Purchase
93,041 +46.1%
107.40
US$4,216,761
93,041 +46.1% 107.40 US$4,216,761